Status:
COMPLETED
Evaluation of the Safety and Efficacy of THL-P in Metastatic Breast Cancer
Lead Sponsor:
Taiwan THL Co.LTd.
Collaborating Sponsors:
National Taiwan University Hospital
Conditions:
Metastatic Breast Cancer
Eligibility:
FEMALE
20-80 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to obtain evidence from test article with efficacy in Metastatic Breast Cancer patients. The average of all changes from baseline to post-treatment evaluations in global h...
Detailed Description
The test article is extracted from many natural herbals, in which most or their components have been shown to have anti-tumor activity. A study in 2004 showed the test article could have strong immuno...
Eligibility Criteria
Inclusion
- Confirmed breast cancer with clinical evidence.
- Life expectancy of at least 4 weeks.
Exclusion
- Any Uncontrolled infection.
- Lupus erythematosus.
- Malignant tumor.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00976365
Start Date
October 1 2009
End Date
June 1 2011
Last Update
June 9 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 110